MyFinsight
Home
Blog
About
Comprehensive loss
-$35,248K
(-43.37%↓ Y/Y)
Unrealized gain on
available-for-sale securities
$7K
Net loss
-$34,673K
(-33.70%↓ Y/Y)
Change in fair value of
notes attributable to...
$582K
(143.14%↑ Y/Y)
Net loss before
taxes
-$33,857K
Income tax expense
$816K
Interest income
$1,108K
Revenue-Product
$25,078K
Revenue-Copiktra License And
Related Assets
$15,000K
Loss from operations
-$32,710K
Change in fair value of
notes
$1,843K
(-38.36%↓ Y/Y)
Total revenue
$40,078K
Interest expense
$360K
(69.81%↑ Y/Y)
Other expense
-$52K
Total operating
expenses
$72,788K
Research and development
$41,338K
Selling, general and
administrative
$27,409K
Cost of sales -
product
$3,762K
Cost of sales -
intangible amortization
$279K
Back
Back
Income Statement
Verastem, Inc. (VSTM)
Verastem, Inc. (VSTM)
source: myfinsight.com